跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,952 条关于
“PI3K pathway”
全部
6,952
临床试验
1,904
药物
144
机构
16
资讯
4,888
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
去年
Paxalisib Plus Radiotherapy Shows Promise in Brain Metastases with PI3K Mutations
2年前
Sysmex Inostics' RAS-RAF-SEQ Assay Gains New York Approval for Clinical Trial Use
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
去年
Daily Aspirin Reduces Colorectal Cancer Recurrence by 55% in Patients with Specific Genetic Mutations
去年
Paxalisib's Glioblastoma Pathway: FDA Suggests Standard Approval, Phase 3 Trial Alignment
去年
Adlai Nortye's AN2025 Shows Promise in Head and Neck Cancer Treatment
去年
Kazia Therapeutics Highlights Clinical Data and Pipeline Progress at November 2024 Corporate Presentation
去年
Novel Anti-Estrogen Therapies Expand Options for Advanced ER+ Breast Cancer
去年
Genentech's Inavolisib Receives FDA Approval for Advanced HR+, HER2- Breast Cancer
第 1 页,共 489 页
上一页
下一页